secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECT MEDICAL HOLDINGS CORP (SEM)
CIK:        0001320414
Form:       8-K
Filed at:   2026-06-22T11:38:15+00:00
Accession:  0001104659-26-076085
Event type: litigation
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Select Medical supplements merger proxy with deal fees, DCF details after stockholder suits
--------------------------------------------------------------------------------

- Three lawsuits in NY and PA allege proxy omissions; company denies but voluntarily adds disclosures.
- Adds $2.9M fee to Ortenzio and $0.2M to Jackson for roles in structuring the transaction.
- Board explored separating critical illness recovery hospital segment from late June 2025.
- Goldman Sachs DCF valuation range per share: $15.04-$25.33; net debt $1.818B; 17 precedent deal premia added.
- Special meeting on merger remains scheduled for June 26, 2026; company urges stockholders to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1320414/000110465926076085/0001104659-26-076085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1320414/000110465926076085/tm2618429d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-076085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer